Mclnnes IB and Schett G (2011): The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205-2219
Koiwa M, Goto S, Takahashi K, et al. (2016): Neutrophil lymphocyte ratio in patients with rheumatoid arthritis treated with biological agents J Nippon Med Sch 83:118-124.
Zochling J and Braun J (2009): Mortality in rheumatoid arthritis and ankylosing spondylitis. Medicine. Clinical and experimental rheumatology.27(4 Suppl 55): S127-30.
Feng JF, Huang Y, and Chen QX (2014): The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl Oncol 7:632-637
Mercan R, Biti k B, Tufan A, et al. (2016): The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal 30:597-601.
Zhang YY, Yin YM, Kuai SC, et al. (2016): Combination of Neutrophil-lymphocyte and platelet-lymphocyte ratios as diagnostic biomarker for rheumatoid arthritis. Int J clin Exp Med 9:22076-22081
Wang J and Arase H (2014): Regulation of immune responses by neutrophils. Annals of the New York Academy of Sciences 1319 (1): p. 66-81, outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 2004;116 (Suppl 7A):50S-57S.
Choi WS, Jeon OH, and Kim DS (2010):CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha (IIb) beta (3). J Thromb Haemost 2010:8:1364-371.
Scarsi M, Zanotti C, Chiarini M, et al. (2014): Reduction of peripheral blood T cells producing IFN- y and IL17 after therapy with abatacept for rheumatoid arthritis. Clin Exp Rheumatol 32:204-210.
Colglazier CL and Sutej PG (2005): Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185-191.
Janta I, Naredo E, Martinez-Estupinan L, et al. (2013): Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography. Rheumatology (Oxford) 52:2243-2250.
FU H, QIN B, HU Z, et al. (2015): Neutrophil-and platelet-to lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab 61:269-273.
Hobbs KF and Cohen MD (2012): Rheumatoid arthritis disease measurement: A new old idea. Rheumatology (Oxford).51(Suppl 6):21-27.
Guthrie GJ, Charles KA, Roxburgh CS, et al. (2013): The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:2018-2030.
Koseoglu HI, Altunkas F, Kanbay A, et al. (2015): Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis 39:179-185.
Kisacik B, Tufan A, kalyoncu U, et al. (2008): Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint bone spine: 75:291-294.
Varache S, Cornec D, Morvan J, et al. (2011): Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort. J Rheumatol 38:1250-1257.
Prevoo ML, van't Hof MA, Kuper HH, et al. (1995): Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 :44-48.
Aletaha D, Ward MM, Machold KP, et al. (2005): Remission and active disease in rheumatoid arthritis. Defining criteria for disease activity states. Arthritis rheum 52:2625-2636.
Van Der Heijde DMFM, Van 't Hof M, and Van De Putte LBA (1993): Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20:579-581.
Fransen J, Creemers M C W, and Van Riel P L C M (2004): Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43:1252-1255.
Ollier R, Harrison B, and Symmons D (2001): What's tire natural history of RA? Best Practice. Res Clin Rheumol 15:27-48
Borah DJ and Iqbal F (2007): Anemia in recent onset Rheumatoid Arthritis. JK Science: 9:120-122
Helal R, EL-Naggar M, Zahra M, et al. (2019): Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Marker of Disease Activity in Rheumatoid Arthritis. Med J Cairo Univ 87:139-145.
Gokmen F, AKbal A, Resorlu H, et al. (2016): Mean platelet volume and neutrophil lymphocyte ratio as related to inflammation markers and Anti-CCP in rheumatoid arthritis. Akttuel Rheumatol 41:488-491.
Lee YH (2018): Association between the neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and rheumatoid arthritis and their correlations with the disease activity: a meta-analysis. J Rheum Dis 25:169.
Muddathir A, Haj F et al. (2013): Platelet indices in sudanese patients with rheumatoid arthritis: Asian Journal of biomedical and pharmaceutical ascience,2013 volumes 3, Issue 23.
Yazici S, Yazici M, Ere-r B, et al. (2010): The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122-125.
Hashizume M, Higuchi Y, Uchiyama Y, et al. (2011): IL-6 plays an essential role in neutrophilia under inflammation. Cytokine 54:92.
Quaiser S, Khan R (2020): Correlation of neutrophil-lymphocyte ratio with disease activity in rheumatoid arthritis. J Clin Sci 17:46-48.
Uslu A, Kucuk A, Sahin A, et al. (2015): Two new inflammatory Markers Associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ration and platelet-lymphocyte ration. Int J Rheum Dis 18:731-735.
Abd Elazeem M and Mohamd R (2017): Neutrophil-lymphocyte and platelet-lymphocyte ratios in rheumatoid arthritis patients: Relation to disease activity. Egypt Rheumatol 40:227-231
Ibrahim T and Mikhael E (2013): Neutrophil/ Lymphocyte ratio in rheumatoid arthritis 9 Iraqi J Pharm Sci, Vol.22(2).